Unrated Drug recall · FDA · Published September 27, 2021

Strides Pharma recalls Potassium Chloride tablets due to failed dissolution

Strides Pharma Inc. recalls Potassium Chloride Extended-Release Tablets (10 mEq) manufactured in India with failed dissolution specifications. No remedy specified in official notice.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0006-2022Drug Strides Pharma ›

Recall notice

Failed Dissolution Specifications

Take action

Contact the company

Recalling firmStrides Pharma Inc.2 Tower Center Blvd Ste 1102 · East Brunswick, NJ 08816-1100

✎ GovInfoNow plain-language explainer

Strides Pharma Inc. is recalling Potassium Chloride Extended-Release Tablets (10 mEq, 500 tablets) because they failed dissolution specifications. This means the tablets may not release potassium chloride properly when taken, potentially causing unsafe potassium levels in the body. Read more at govinfonow.com/recall/35838-strides-pharma-recalls-potassium-chloride-tablets-due-to-failed-dissolution.

Source Summary by GovInfoNow · govinfonow.com/recall/35838-strides-pharma-recalls-potassium-chloride-tablets-due-to-failed-dissolution · Updated August 18, 2026 · FDA enforcement record: FDA #D-0006-2022

Cite this page

“Strides Pharma recalls Potassium Chloride tablets due to failed dissolution.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35838-strides-pharma-recalls-potassium-chloride-tablets-due-to-failed-dissolution. Based on FDA recall #D-0006-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0006-2022%22&limit=1).

The FDA announced on 2021-09-27 that Strides Pharma Inc. voluntarily recalled Potassium Chloride Extended-Release Tablets due to failed dissolution specifications. The recall affects 1,813 bottles distributed nationwide.

How to tell if you have it

Brand: Strides Pharma
Product: Potassium Chloride Extended-Release Tablets, USP 10 mEq (750 mg)
Quantity: 500 Tablets per bottle
NDC: 64380-861-07
Lot Code: 7240840A
Expiration Date: 12/31/2021
Manufacturer: Strides Shasun Limited, Bengaluru - 562106, India
Distributor: Strides Pharma In., East Brunswick, NJ 08816

The hazard

The tablets failed dissolution specifications. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Strides Pharma Inc. has had 9 other recalls on record since 2017-05-09. Other recent recalls of similar products include Taro Recalls Children's Ibuprofen Due to Foreign Substance (2026-03-02), Strides Pharma Cinacalcet Tablets 90mg Recall: Failed Dissolution Specifications (2025-07-09), and Strides Pharma Recalls Testosterone Gel Due to Benzene Contamination (2025-03-05). Other recent recalls of similar products include Golden State Medical Recalls Prasugrel HCl 10mg Tablets (2026-08-21), Teva Metoprolol Succinate Tablets Recall: Failed Dissolution Specifications (2026-01-29), and Golden State NIACIN Extended-Release Tablets Recall: Failed Dissolution Testing (2026-05-29).

How to tell if you have this one

Check for the product name 'Potassium Chloride Extended-Release Tablets, USP 10 mEq (750 mg), 500 Tablets, Rx Only' with manufacturer Strides Shasun Limited. The lot number 7240840A and expiration date 12/31/2021 are specific identifiers for this recall.

Brand
Strides Pharma
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Details
Look for the product name, lot number 7240840A, and expiration date 12/31/2021 on the packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 13 months after the firm started it.

Sep 27, 2021Firm started the recall
Oct 8, 2021FDA classified it Class II
Oct 20, 2021Published in FDA’s Enforcement Report
Oct 26, 2022FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

From the GovInfoNow team · based on the FDA notice · How we make summaries

Is there a risk of serious injury from this product?

The recall notice does not describe a specific hazard mechanism that could cause serious injury, so the risk level is unknown.

Similar recalls

Other Strides Pharma recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/35838-strides-pharma-recalls-potassium-chloride-tablets-due-to-failed-dissolution">Strides Pharma recalls Potassium Chloride tablets due to failed dissolution (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0006-2022 (September 27, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0006-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.